Ole Schmeltz Sogaard
Overview
Explore the profile of Ole Schmeltz Sogaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
863
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reekie J, Stovring H, Nielsen H, Johansen I, Benfield T, Wiese L, et al.
Int J Infect Dis
. 2024 May;
146:107111.
PMID: 38801970
Objectives: This study aimed to compare antibody trajectories among individuals with SARS-CoV-2 hybrid and vaccine-induced immunity. Methods: Danish adults receiving three doses of BTN162b2 or mRNA-1237 were included prior to...
2.
Juhl A, Dietz L, Sogaard O, Reekie J, Nielsen H, Johansen I, et al.
J Infect Dis
. 2024 Apr;
230(3):e605-e615.
PMID: 38687181
Background: Within a year of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, vaccines inducing a robust humoral and cellular immune response were implemented worldwide. However, emergence of novel...
3.
Sugiyama F, Dietz L, Sogaard O
Curr Opin HIV AIDS
. 2024 Apr;
19(4):187-193.
PMID: 38686856
Purpose Of Review: Advancements in antiretroviral therapy (ART) have positively impacted the life expectancy and possibility of living a normal life for people with HIV-1. However, lifelong daily medication is...
4.
Gunst J, Sogaard O
NEJM Evid
. 2024 Feb;
2(11):EVIDe2300222.
PMID: 38320534
Not long after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of coronavirus disease 2019 (Covid-19), in vitro experiments revealed that SARS-CoV-2 infection of human cells...
5.
Hvidt A, Guo H, Andersen R, Lende S, Vibholm L, Sogaard O, et al.
BMC Immunol
. 2023 Nov;
24(1):45.
PMID: 37974069
Background: SARS-CoV-2 remains a world-wide health issue. SARS-CoV-2-specific immunity is induced upon both infection and vaccination. However, defining the long-term immune trajectory, especially after infection, is limited. In this study,...
6.
Ammitzboll C, Thomsen M, Andersen J, Jensen J, Bayarri-Olmos R, Garred P, et al.
Clin Exp Rheumatol
. 2023 Oct;
42(1):157-165.
PMID: 37877429
Objectives: To investigate the effect of COVID-19 mRNA revaccination (two doses) on the antibody response in patients with rheumatic diseases (RD) who were initial vaccine non-responders. Further, to examine if...
7.
Schou M, Sogaard O, Rasmussen T
Expert Rev Anti Infect Ther
. 2023 Oct;
21(11):1227-1243.
PMID: 37856845
Introduction: The main barrier to finding a cure against HIV is the latent HIV reservoir, which persists in people living with HIV (PLWH) despite antiretroviral treatment (ART). Here, we discuss...
8.
Rothemejer F, Lauritsen N, Sogaard O, Tolstrup M
Front Immunol
. 2023 Sep;
14:1253395.
PMID: 37671164
Chimeric Antigen Receptor (CAR) T cell therapies are tremendously successful in hematological malignancies and show great promise as treatment and curative strategy for HIV. A major determinant for effective CAR...
9.
Bannister W, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, et al.
Open Forum Infect Dis
. 2023 Jun;
10(6):ofad248.
PMID: 37351453
Background: Side effects to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are a key concern contributing to vaccine hesitancy, but more individuals may be encouraged if SARS-CoV-2 vaccines were...
10.
Frattari G, Caskey M, Sogaard O
Curr Opin HIV AIDS
. 2023 May;
18(4):157-163.
PMID: 37144579
Purpose Of Review: In recent years, clinical trials have explored broadly neutralizing antibodies (bNAbs) as treatment and cure of HIV. Here, we summarize the current knowledge, review the latest clinical...